Epidermal Growth Factor Receptor Gene

What the Epidermal Growth Factor Receptor Gene Means

The Epidermal Growth Factor Receptor Gene, commonly called the EGFR gene, is a part of your body's instructions for making a protein known as the epidermal growth factor receptor. This protein is found on the surface of some cells and helps control how they grow, divide, and survive. When the EGFR gene works normally, it helps keep cell growth balanced and healthy.

Sometimes, changes called mutations occur in the EGFR gene. These mutations can cause the protein to be made in larger amounts or become overactive. When this happens, cells may grow too quickly and form cancer. Such changes are found in some cancers, especially certain non-small cell lung cancers.

Why the EGFR Gene Matters in Cancer Care

Knowing whether a tumor has changes in the EGFR gene can help doctors choose treatments that specifically target the EGFR protein. These targeted therapies work by blocking the signals that tell cancer cells to grow and divide, which may slow or stop the cancer’s growth. This approach is part of personalized cancer care, where treatments are tailored to the unique features of a patient’s tumor.

What Patients Might See or Hear About the EGFR Gene

You might hear your care team mention the EGFR gene when discussing test results or treatment options. The gene may also be called the epidermal growth factor receptor gene, ERBB1 gene, or HER1 gene. These different names refer to the same gene, so it’s helpful to ask your care team if you’re unsure. If your tumor has changes in the EGFR gene, your doctor might talk about targeted drugs that block the EGFR protein.

How Doctors Use EGFR Gene Information

Doctors often test tumor tissue for EGFR gene mutations when lung cancer is diagnosed or if the cancer has returned or worsened after treatment. Finding these mutations can help decide if targeted therapies are a good option. These drugs are usually considered when standard chemotherapy is less effective or not suitable. The choice to use EGFR-targeted treatments depends on many factors, including the specific mutations found, the type and stage of cancer, and the patient’s overall health.

What the EGFR Gene Does Not Automatically Mean

Seeing the term EGFR gene in your medical records or hearing it mentioned does not mean you have a specific diagnosis or that a particular treatment is guaranteed to work. It is one part of a larger picture your care team uses to plan your care. Not all cancers have EGFR mutations, and not all patients with these mutations respond the same way to targeted treatments. It’s important to discuss what your test results mean for you personally.

Common Questions to Ask Your Care Team

If the EGFR gene comes up in your care, you might ask: What does this gene change mean for my cancer? Are there targeted treatments available for my situation? What are the possible benefits and side effects of these treatments? How will we monitor if the treatment is working? Are there clinical trials or other options I should consider? These questions can help you understand your care and feel more involved in decisions.

Understanding Different Names and Avoiding Confusion

The EGFR gene is also called ERBB1 gene or HER1 gene. These names all refer to the same gene. Because reports or discussions may use different terms, it’s helpful to compare wording and ask your care team if you’re unsure what a term means in your specific case.

Safety and Next Steps

This information is educational and does not decide what is safe, appropriate, or effective for any individual patient. If the term EGFR gene appears in your medical records or discussions, the safest next step is to ask your care team what it means in that exact report, test result, treatment plan, or symptom discussion. Understanding this term can help you be more informed and involved in your care decisions.